Tech Company Financing Transactions

Civitas Therapeutics Funding Round

Civitas Therapeutics, based in Chelsea, secured $38 million from Bay City Capital, Alkermes and Canaan Partners.

Transaction Overview

Company Name
Civitas Therapeutics
Announced On
9/11/2013
Transaction Type
Venture Equity
Amount
$38,000,000
Round
Series B
Investors

Bay City Capital (Lead Investor) (Robert Hopfner)

Alkermes

Canaan Partners (Timothy Shannon)

Fountain Healthcare Partners

Longitude Capital Management (David Hirsch)

RA Capital (Rajeev Shah)

Proceeds Purpose
Civitas plans to use the proceeds from this financing for late stage clinical development of the company's lead program, CVT-301, an inhaled formulation of levodopa (L-dopa) being developed for the rapid and reliable relief from debilitating motor fluctuations (OFF episodes) associated with Parkinson's disease.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
190 Everett Ave.
Chelsea, MA 02150
USA
Phone
617.660.4110
Website
www.civitastherapeutics.com
Email Address
[email protected]
Overview
Civitas is a pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device.
Profile
Civitas Therapeutics LinkedIn Company Profile
Social Media
Civitas Therapeutics Company Twitter Account
Company News
Civitas Therapeutics News
Facebook
Civitas Therapeutics on Facebook
YouTube
Civitas Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Iwicki
  Mark Iwicki LinkedIn Profile  Mark Iwicki Twitter Account  Mark Iwicki News  Mark Iwicki on Facebook
Chief Medical Officer
Martin Freed
  Martin Freed LinkedIn Profile  Martin Freed Twitter Account  Martin Freed News  Martin Freed on Facebook
Chief Scientific Officer
Rick Batycky
  Rick Batycky LinkedIn Profile  Rick Batycky Twitter Account  Rick Batycky News  Rick Batycky on Facebook
VP - Regulatory Affairs
Mary Taylor
  Mary Taylor LinkedIn Profile  Mary Taylor Twitter Account  Mary Taylor News  Mary Taylor on Facebook
VP - Sales
Bryan Stuart
  Bryan Stuart LinkedIn Profile  Bryan Stuart Twitter Account  Bryan Stuart News  Bryan Stuart on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/10/2013: Songza Media venture capital transaction
Next: 9/11/2013: NextDocs venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.